Fol. Biol. 2013, 59, 162-167
https://doi.org/10.14712/fb2013059040162
Inhibition of mTORC1 by SU6656, the Selective Src Kinase Inhibitor, Is Not Accompanied by Activation of Akt/PKB Signalling in Melanoma Cells
Individual author index pages
Other articles of these authors
-
Molecular Therapeutics Lessons from the Role of Src in Cellular Signalling
Zdena Tuháčková
2005, Vol. 51, Issue 4, pp. 114-120
